Union Minister Piyush Goyal said he held a meeting with Janet Truncale, Global Chair and CEO of EY, to discuss India's growing role in glob...

As global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...

Shares of Sun Pharmaceutical Industries fell sharply after ET reported the company had submitted a $12-billion binding offer for Organon & ...

Sun Pharmaceutical Industries is nearing a $12 billion acquisition of Organon & Co, marking its most significant overseas expansion. Follow...

India's Biotechnology Industry Research Assistance Council, BIRAC, marked its 14th Foundation Day. It has significantly boosted India's bio...

Piramal Pharma swung to a Rs 136 crore Q3 loss as revenue fell 3%, hit by CDMO destocking, weak US biopharma funding, trade uncertainty and...

Piramal Pharma's US facility inspection concluded with four observations from the FDA. The company expects a voluntary action indicated cla...

HealthKois is aiming at a first close at the end of this year or early 2026. The investments will be deployed over the next four years, wit...

Syngene International also expects business growth from its pharma clients who are keen to make up for the time that they felt they lost du...

In the letter written on May 13, Arun Kumar, Founder and Director of Stelis Biopharma Limited, said that after the prime minister had reque...

The latest round also saw participation from existing investors Accel and Bharat Innovation Fund, bringing the total capital raised by the ...

In an interaction with the Russian president Vladimir Putin on Friday through a video conference, Hetero group’s Chairman Dr Bandi Parthasa...

The Central Drugs Standard Control Organisation (CDSCO) is presently regulating 28 categories of notified medical devices under the provisi...

Shares of Strides Arcolab were today trading at Rs 667.60 per scrip in the morning trade on BSE, up 2.54 per cent from its previous close.

India's bio-pharma sector may see a surge in R&D spending to about $25 billion in the next 15 years, according to a Boston Consulting Group...

One of the leaders in the Biopharma world, UCB is deep into research on very critical health issues. In a chat ,Charles-Antoine Janssen Man...

The Bid for Cambrex, a New Jersey-based life sciences company, could become an India affair.